首页> 外文期刊>Journal of Drug Delivery >Cell Uptake and Validation of Novel PECs for Biomedical Applications
【24h】

Cell Uptake and Validation of Novel PECs for Biomedical Applications

机译:用于生物医学应用的新型PEC的细胞吸收和验证

获取原文
       

摘要

This pilot study provides the proof of principle for biomedical application of novel polyelectrolyte complexes (PECs) obtainedviaelectrostatic interactions between dextran sulphate (DXS) and poly(allylamine hydrochloride) (PAH). Scanning electron microscopy (SEM) and atomic force microscopy (AFM) showed that DXS/PAH polyelectrolyte complexes were Monodispersed with regular rounded-shape features and average diameters of 250 nm at 2 : 1 weight ratios of DXS/PAH. Fluorescently labelled DXS and fluorescein-isothiocyanate- (FITC-)conjugate DXS were used to follow cell uptake efficiency of PECs and biodegradability of their enzymatically degradable DXS-layers by using confocal laser scanning microscopy (CLSM). Moreover, quantitative MTT and Trypan Blue assays were employed to validate PECs as feasible and safe nanoscaled carriers at single-cell level without adverse effects on metabolism and viability.
机译:这项初步研究为通过硫酸右旋糖酐(DXS)和聚(烯丙胺盐酸盐)(PAH)之间的静电相互作用获得的新型聚电解质复合物(PEC)的生物医学应用提供了原理证明。扫描电子显微镜(SEM)和原子力显微镜(AFM)表明,DXS / PAH聚电解质复合物呈单分散,具有规则的圆形特征,在DXS / PAH的重量比为2:1时平均直径为250 nm。使用共聚焦激光扫描显微镜(CLSM),使用荧光标记的DXS和荧光素-异硫氰酸酯(FITC-)缀合物DXS跟踪PEC的细胞吸收效率及其可酶降解的DXS层的生物降解性。此外,采用定量MTT和台盼蓝测定法来验证PECs在单细胞水平上是可行且安全的纳米级载体,而对代谢和生存力无不利影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号